Thrive Launches with $110 Million Series A Financing to Integrate Earlier Detection of Multiple Cancer Types into Routine Medical Care
Company Advancing CancerSEEK, A DNA- and Protein-based Liquid Biopsy Test Developed by The Vogelstein Lab at Johns Hopkins University 10,000...